Volume 13 Issue 3
May  2022
Turn off MathJax
Article Contents
Guo Hui, Chen Zhishui. Diagnostic criteria and its progress on intestinal graft pathology[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 307-316. doi: 10.3969/j.issn.1674-7445.2022.03.005
Citation: Guo Hui, Chen Zhishui. Diagnostic criteria and its progress on intestinal graft pathology[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 307-316. doi: 10.3969/j.issn.1674-7445.2022.03.005

Diagnostic criteria and its progress on intestinal graft pathology

doi: 10.3969/j.issn.1674-7445.2022.03.005
More Information
  • Corresponding author: Chen Zhishui, Email: zschen@tjh.tjmu.edu.cn
  • Received Date: 2022-03-21
    Available Online: 2022-04-29
  • Publish Date: 2022-05-15
  • Intestinal transplantation has become the most ideal treatment for intestinal failure. Modern clinical intestinal transplantation includes three types: isolated intestinal transplantation, combined liver-intestinal transplantation and abdominal multivisceral transplantation. The immunological, anatomical and physiological characteristics of intestinal grafts significantly differ from those of other solid transplant organs. Consequently, intestinal grafts could develop specific and severe complications, such as acute rejection, chronic rejection, graft-versus-host disease (GVHD), infection and posttransplant lymphoproliferative disease (PTLD), among which acute rejection and infection are extremely challenging. Endoscopic examination and intestinal mucosal biopsy of intestinal grafts could be performed to make timely diagnosis and differentiation of these complications, then deliver targeted treatment and guarantee the long-term survival of recipients and intestinal grafts.

     

  • loading
  • [1]
    VENICK RS. Current review on the role of ileostomy following intestinal transplantation[J]. Curr Opin Organ Transplant, 2022, 27(2): 126-130. DOI: 10.1097/MOT.0000000000000966.
    [2]
    MIZUSHIMA T, UDAGAWA E, HASEGAWA M, et al. Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study[J]. Surg Today, 2022, DOI: 10.1007/s00595-022-02469-9[Epub ahead of print].
    [3]
    MCCALLUM Z, DELANY C, GILLAM L. Crossing the line? ethics of parenteral nutrition in paediatric neurodisability complicated by intestinal failure[J]. Arch Dis Child, 2022, DOI: 10.1136/archdischild-2021-323500[Epub ahead of print].
    [4]
    MEROLA J, SHAMIM A, WEINER J. Update on immunosuppressive strategies in intestinal transplantation[J]. Curr Opin Organ Transplant, 2022, 27(2): 119-125. DOI: 10.1097/MOT.0000000000000958.
    [5]
    FORTUNATO AC, PINHEIRO RS, MATSUMOTO CS, et al. Techniques for closing the abdominal wall in intestinal and multivisceral transplantation: a systematic review[J]. Ann Transplant, 2022, 27: e934595. DOI: 10.12659/AOT.934595.
    [6]
    LERUT JP, GONDOLESI GE. Immunosuppression in liver and intestinal transplantation[J]. Best Pract Res Clin Gastroenterol, 2021, 54/55: 101767. DOI: 10.1016/j.bpg.2021.101767.
    [7]
    WICHMANN D, NADALIN S, SCHWEIZER U, et al. Evaluating the diagnostic value of zoom endoscopic surveillance compared to routine biopsy after intestinal transplantation[J]. Dig Liver Dis, 2022, 54(3): 385-390. DOI: 10.1016/j.dld.2021.12.019.
    [8]
    DUCLAUX-LORAS R, BERTHILLER J, FERRONI A, et al. Clostridium difficile: a frequent infection in children after intestinal transplantation[J]. Transplantation, 2020, 104(1): 197-200. DOI: 10.1097/TP.0000000000002795.
    [9]
    SUDAN DL, KAUFMAN S, HORSLEN S, et al. Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients[J]. Transplant Proc, 2000, 32(6): 1199. DOI: 10.1016/s0041-1345(00)01182-9.
    [10]
    李元新, 黎介寿, 李宁, 等. 人体小肠移植的内窥镜监测[J]. 中华器官移植杂志, 1997, 18(4): 229-230. DOI: 10.3760/cma.j.issn.0254-1785.1997.04.019.

    LI YX, LI JT, LI N, et al. Endoscopic observation of human small intestinal transplantation[J]. Chin J Organ Transplant, 1997, 18(4): 229-230. DOI: 10.3760/cma.j.issn.0254-1785.1997.04.019.
    [11]
    郭晖. 小肠移植排斥反应病理学[M]//陈实. 移植免疫学. 武汉: 湖北科技出版社, 1998: 235-237.
    [12]
    MOON JI, SCHIANO TD, IYER KR. Routine surveillance endoscopy and biopsy after isolated intestinal transplantation-revisiting the gold standard[J]. Clin Transplant, 2019, 33(10): e13684. DOI: 10.1111/ctr.13684.
    [13]
    JELLY ET, KWUN J, SCHMITZ R, et al. Optical coherence tomography of small intestine allograft biopsies using a handheld surgical probe[J]. J Biomed Opt, 2021, 26(9): 096008. DOI: 10.1117/1.JBO.26.9.096008.
    [14]
    CRISMALE JF, MAHMOUD D, MOON J, et al. The role of endoscopy in the small intestinal transplant recipient: a review[J]. Am J Transplant, 2021, 21(5): 1705-1712. DOI: 10.1111/ajt.16354.
    [15]
    KÖNIGSRAINER A, LADURNER R, IANNETTI C, et al. The 'blind innsbruck ostomy', a cutaneous enterostomy for long-term histologic surveillance after small bowel transplantation[J]. Transpl Int, 2007, 20(10): 867-874. DOI: 10.1111/j.1432-2277.2007.00541.x.
    [16]
    GULLEROGLU K, BASKIN E, OZDEMIR H, et al. Clinical impact of complement deposition findings on biopsies in acute rejection episodes of pediatric renal transplant patients[J]. Transpl Immunol, 2021, 69: 101466. DOI: 10.1016/j.trim.2021.101466.
    [17]
    FUJINO T, KUMAI Y, YANG B, et al. Discordance between immunofluorescence and immunohistochemistry C4d staining and outcomes following heart transplantation[J]. Clin Transplant, 2021, 35(4): e14242. DOI: 10.1111/ctr.14242.
    [18]
    ŁABUŚ A, MUCHA K, KULESZA A, et al. Costs of treatment of acute antibody-mediated rejection in kidney transplant recipients[J]. Transplant Proc, 2022, DOI: 10.1016/j.transproceed.2021.11.039[Epub ahead of print].
    [19]
    LOUIS K, MACEDO C, LEFAUCHEUR C, et al. Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection[J]. Trends Mol Med, 2022, 28(3): 237-250. DOI: 10.1016/j.molmed.2022.01.002.
    [20]
    WU GS, CRUZ RJ JR, CAI JC. Acute antibody-mediated rejection after intestinal transplantation[J]. World J Transplant, 2016, 6(4): 719-728. DOI: 10.5500/wjt.v6.i4.719.
    [21]
    STOBUTZKI N, SCHLICKEISER S, STREITZ M, et al. Long-term signs of T cell and myeloid cell activation after intestinal transplantation with cellular rejections contributing to further increase of CD16+ cell subsets[J]. Front Immunol, 2019, 10: 866. DOI: 10.3389/fimmu.2019.00866.
    [22]
    SPAGGIARI M, LICHVAR A, TZVETANOV I, et al. Temporary deceased donor splenic transplant prior to intestinal transplantation: a new strategy for desensitization?[J]. Transplant Proc, 2021, 53(8): 2602-2608. DOI: 10.1016/j.transproceed.2021.08.008.
    [23]
    MATSUMOTO CS, ROSEN-BRONSON S. Donor-specific antibody and sensitized patients in intestinal transplantation[J]. Curr Opin Organ Transplant, 2021, 26(2): 245-249. DOI: 10.1097/MOT.0000000000000853.
    [24]
    GAITONDE S, HASSAN M, MEHTA V, et al. Histopathology of human donor spleen utilized as a desensitization tool before intestinal transplantation[J]. Am J Clin Pathol, 2021, 155(5): 621-626. DOI: 10.1093/ajcp/aqaa175.
    [25]
    CORREA-MARTÍNEZ CL, BECKER F, SCHWIERZECK V, et al. Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation[J]. Antimicrob Resist Infect Control, 2020, 9(1): 180. DOI: 10.1186/s13756-020-00845-z.
    [26]
    ÅBERG F, SAVIKKO J, ANTTILA VJ, et al. Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report[J]. Clin Case Rep, 2018, 6(7): 1232-1235. DOI: 10.1002/ccr3.1493.
    [27]
    STANLEY K, RANGANATHAN S, MAZARIEGOS G, et al. Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: case report and review of the literature[J]. Pediatr Transplant, 2019, 23(2): e13350. DOI: 10.1111/petr.13350.
    [28]
    GERLACH UA, MORLAND B, HOBIN D, et al. Atypical malignancies after intestinal transplantation in children: a European single-centre experience[J]. Pediatr Transplant, 2020, 24(3): e13697. DOI: 10.1111/petr.13697.
    [29]
    KAUFMAN SS, HUSSAN E, KROEMER A, et al. Graft versus host disease after intestinal transplantation: a single-center experience[J]. Transplant Direct, 2021, 7(8): e731. DOI: 10.1097/TXD.0000000000001187.
    [30]
    GANOZA A, MAZARIEGOS GV, KHANNA A. Current status of graft-versus-host disease after intestinal transplantation[J]. Curr Opin Organ Transplant, 2019, 24(2): 199-206. DOI: 10.1097/MOT.0000000000000624.
    [31]
    OLTEAN M. Intestinal transplantation: an overview of the recent experimental studies[J]. Curr Opin Organ Transplant, 2021, 26(2): 240-244. DOI: 10.1097/MOT.0000000000000845.
    [32]
    DEVINE K, RANGANATHAN S, MAZARIEGOS G, et al. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: single-center experience[J]. Pediatr Transplant, 2020, 24(5): e13723. DOI: 10.1111/petr.13723.
    [33]
    CHIOU FK, BEATH SV, MORLAND B, et al. Comparison of clinical features and outcome of pediatric posttransplant lymphoproliferative disorder in recipients of small bowel allograft versus isolated liver transplantation[J]. Transplantation, 2020, 104(7): 1429-1436. DOI: 10.1097/TP.0000000000003004.
    [34]
    ANDRES AM, RAMOS E, HERNANDEZ F. Current status of pediatric intestinal transplant in Europe[J]. Curr Opin Organ Transplant, 2020, 25(2): 183-188. DOI: 10.1097/MOT.0000000000000736.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(9)

    Article Metrics

    Article views (415) PDF downloads(87) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return